ES433990A1 - Procedimiento para la preparacion de derivados de diaminoci-clitoles. - Google Patents
Procedimiento para la preparacion de derivados de diaminoci-clitoles.Info
- Publication number
- ES433990A1 ES433990A1 ES433990A ES433990A ES433990A1 ES 433990 A1 ES433990 A1 ES 433990A1 ES 433990 A ES433990 A ES 433990A ES 433990 A ES433990 A ES 433990A ES 433990 A1 ES433990 A1 ES 433990A1
- Authority
- ES
- Spain
- Prior art keywords
- gentamicin
- antibiotic
- amino
- derivatives
- translation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000002253 acid Substances 0.000 abstract 4
- 229930182566 Gentamicin Natural products 0.000 abstract 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 abstract 3
- 229960002518 gentamicin Drugs 0.000 abstract 3
- 125000003277 amino group Chemical group 0.000 abstract 2
- LKKVGKXCMYHKSL-LLZRLKDCSA-N gentamycin A Chemical compound O[C@H]1[C@H](NC)[C@@H](O)CO[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](N)C[C@H]1N LKKVGKXCMYHKSL-LLZRLKDCSA-N 0.000 abstract 2
- 125000006239 protecting group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- CEAZRRDELHUEMR-CAMVTXANSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-[(1r)-1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1[C@H]([C@@H](C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-CAMVTXANSA-N 0.000 abstract 1
- XUFIWSHGXVLULG-BSBKYKEKSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-[(1s)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)[C@H](C)N)N)[C@@H](N)C[C@H]1N XUFIWSHGXVLULG-BSBKYKEKSA-N 0.000 abstract 1
- BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 abstract 1
- XUSXOPRDIDWMFO-CTMSJIKGSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[[(2s,3r)-3-amino-6-[(1s)-1-aminoethyl]-3,4-dihydro-2h-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(O2)[C@H](C)N)N)[C@@H](N)C[C@H]1N XUSXOPRDIDWMFO-CTMSJIKGSA-N 0.000 abstract 1
- ABCLPPNEPBAKRL-ROQIPNNMSA-N (2r,3s,4s,5r,6s)-2-[(1r)-1-aminoethyl]-6-[(1r,2r,3s,4r,6s)-4,6-diamino-3-[(2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)N)O2)O)[C@@H](N)C[C@H]1N ABCLPPNEPBAKRL-ROQIPNNMSA-N 0.000 abstract 1
- DAKDDLIZULPEFW-UHFFFAOYSA-N 2-[4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-4-(methylamino)oxane-3,5-diol Chemical compound OC1C(NC)C(O)COC1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N DAKDDLIZULPEFW-UHFFFAOYSA-N 0.000 abstract 1
- -1 Antibiotic 66-40B Chemical compound 0.000 abstract 1
- VIAXDDBFFSKHGA-UHFFFAOYSA-N Antibiotic G52 Natural products CNC1CC(N)C(OC2OCC(C)(O)C(NC)C2O)C(O)C1OC3OC(=CCC3N)CN VIAXDDBFFSKHGA-UHFFFAOYSA-N 0.000 abstract 1
- WYJSPPYVEJPMJA-DJWUNRQOSA-N Antibiotic JI-20B Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)N)O2)N)[C@@H](N)C[C@H]1N WYJSPPYVEJPMJA-DJWUNRQOSA-N 0.000 abstract 1
- HFLKNINDVFJPQT-UHFFFAOYSA-N Gentamicin X2 Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(C(O)C(O)C(CO)O2)N)C(N)CC1N HFLKNINDVFJPQT-UHFFFAOYSA-N 0.000 abstract 1
- HFLKNINDVFJPQT-ZFAMMYHGSA-N Gentamicin X2 Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](N)C[C@H]1N HFLKNINDVFJPQT-ZFAMMYHGSA-N 0.000 abstract 1
- URWAJWIAIPFPJE-UHFFFAOYSA-N Rickamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N URWAJWIAIPFPJE-UHFFFAOYSA-N 0.000 abstract 1
- XUSXOPRDIDWMFO-UHFFFAOYSA-N Verdamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(O2)C(C)N)N)C(N)CC1N XUSXOPRDIDWMFO-UHFFFAOYSA-N 0.000 abstract 1
- ARCVBMPERJRMKB-UHFFFAOYSA-N antibiotic g-52 Chemical compound O1C(CNC)=CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N ARCVBMPERJRMKB-UHFFFAOYSA-N 0.000 abstract 1
- RHRAMPXHWHSKQB-GGEUKFTFSA-N betamicin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)O)[C@@H](N)C[C@H]1N RHRAMPXHWHSKQB-GGEUKFTFSA-N 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 150000001718 carbodiimides Chemical class 0.000 abstract 1
- RHRAMPXHWHSKQB-UHFFFAOYSA-N gentamicin B Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(C(O)C(O)C(CN)O2)O)C(N)CC1N RHRAMPXHWHSKQB-UHFFFAOYSA-N 0.000 abstract 1
- DNYGXMICFMACRA-UHFFFAOYSA-N gentamicin C1A Natural products O1C(CNC)CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N DNYGXMICFMACRA-UHFFFAOYSA-N 0.000 abstract 1
- 229930076781 gentamycin C1 Natural products 0.000 abstract 1
- VEGXETMJINRLTH-BOZYPMBZSA-N gentamycin C1a Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N VEGXETMJINRLTH-BOZYPMBZSA-N 0.000 abstract 1
- XUFIWSHGXVLULG-JYDJLPLMSA-N gentamycin C2 Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)[C@@H](C)N)N)[C@@H](N)C[C@H]1N XUFIWSHGXVLULG-JYDJLPLMSA-N 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- URWAJWIAIPFPJE-YFMIWBNJSA-N sisomycin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-YFMIWBNJSA-N 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
- C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45257174A | 1974-03-19 | 1974-03-19 | |
US05/452,586 US4029882A (en) | 1974-03-19 | 1974-03-19 | Selective acylation of the C-1 amino group of aminoglycoside antibiotics |
CH1060174 | 1974-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES433990A1 true ES433990A1 (es) | 1977-03-01 |
Family
ID=27176473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES433990A Expired ES433990A1 (es) | 1974-03-19 | 1975-01-21 | Procedimiento para la preparacion de derivados de diaminoci-clitoles. |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPS5843398B2 (xx) |
AT (1) | AT341088B (xx) |
DD (1) | DD117871A5 (xx) |
DK (1) | DK156070C (xx) |
ES (1) | ES433990A1 (xx) |
FI (1) | FI60714C (xx) |
HU (1) | HU175673B (xx) |
IT (1) | IT1049348B (xx) |
LU (1) | LU71687A1 (xx) |
NL (1) | NL183826C (xx) |
NO (1) | NO140426C (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2390255T (pt) * | 2006-04-03 | 2016-10-24 | Technion Res & Dev Foundation | Novos aminoglicosídeos e utilizações destes no tratamento de distúrbios genéticos |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3780018A (en) * | 1972-06-26 | 1973-12-18 | Bristol Myers Co | Derivatives of gentamicin c1 |
US3796698A (en) * | 1972-10-18 | 1974-03-12 | Bristol Myers Co | Antibiotic derivatives of gentamicin c2 |
US3796699A (en) * | 1972-11-06 | 1974-03-12 | Bristol Myers Co | Antibiotic derivatives of gentamicin c1a |
-
1975
- 1975-01-21 NO NO750168A patent/NO140426C/no unknown
- 1975-01-21 LU LU71687*A patent/LU71687A1/xx unknown
- 1975-01-21 NL NLAANVRAGE7500690,A patent/NL183826C/xx not_active IP Right Cessation
- 1975-01-21 IT IT19435/75A patent/IT1049348B/it active
- 1975-01-21 FI FI750141A patent/FI60714C/sv not_active IP Right Cessation
- 1975-01-21 AT AT42975A patent/AT341088B/de not_active IP Right Cessation
- 1975-01-21 ES ES433990A patent/ES433990A1/es not_active Expired
- 1975-01-22 JP JP50009654A patent/JPS5843398B2/ja not_active Expired
- 1975-01-22 DK DK018675A patent/DK156070C/da not_active IP Right Cessation
- 1975-01-23 DD DD183784A patent/DD117871A5/xx unknown
- 1975-01-23 HU HU75SCHE507A patent/HU175673B/hu unknown
Also Published As
Publication number | Publication date |
---|---|
LU71687A1 (xx) | 1975-12-09 |
NL7500690A (nl) | 1975-09-23 |
JPS5843398B2 (ja) | 1983-09-27 |
FI60714B (fi) | 1981-11-30 |
NO140426C (no) | 1979-08-29 |
JPS50126640A (xx) | 1975-10-04 |
NO140426B (no) | 1979-05-21 |
DK18675A (xx) | 1975-09-20 |
AT341088B (de) | 1978-01-25 |
NO750168L (xx) | 1975-09-22 |
IT1049348B (it) | 1981-01-20 |
FI750141A (xx) | 1975-09-20 |
FI60714C (fi) | 1982-03-10 |
DK156070C (da) | 1989-11-06 |
HU175673B (hu) | 1980-09-28 |
DK156070B (da) | 1989-06-19 |
ATA42975A (de) | 1977-05-15 |
NL183826C (nl) | 1989-02-01 |
NL183826B (nl) | 1988-09-01 |
DD117871A5 (xx) | 1976-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0495776T3 (da) | Stabiliserende nitrogenoxid/primær amin-komplekser, der er anvendelige som cardiovaskulære midler | |
JPS5756485A (en) | Cephem of penam compound and its preparation | |
FI812693L (fi) | Benzoxazinderivat | |
GB1473733A (en) | Pseudotrisaccharides and methods for their production | |
BR9813317A (pt) | Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto | |
JPS5356661A (en) | Novel amino glycoside antibiotics derivatives | |
ES467964A1 (es) | Procedimiento para la obtencion de derivados de los pseudo- trisacaridos. | |
CA2307788A1 (en) | 2-halo-6-o-substituted ketolide derivatives | |
IE40796L (en) | Diaminocyclitols derivatives | |
JPS57131759A (en) | 2-oxoazetidine derivative, its preparation and use | |
ES433990A1 (es) | Procedimiento para la preparacion de derivados de diaminoci-clitoles. | |
ES459832A1 (es) | Procedimiento para preparar un aminoglicosido de 2-deoxies- treptamina. | |
JPS5798288A (en) | Novel cephem compound or its salt, their preparation, and preventive and remedy for bacteriosis containing said compound as active component | |
GB1530643A (en) | Aminoglycosides | |
ES421251A1 (es) | Procedimiento para la produccion de un derivado 3'-desoxi de un antibiotico aminoglicosidico. | |
ES469303A1 (es) | Un procedimiento para la preparacion de una 1-n-( amino- - hidroxialcanoil)kanamicina a o b | |
ES449457A1 (es) | Procedimiento para la preparacion de nuevos pseudotrisacari-dos. | |
ES428892A1 (es) | Procedimiento para la preparacion de nuevos pseudotrisacari-dos. | |
ES407519A1 (es) | Procedimiento para la preparacion de nuevas 2-(5-nitro-2- furil)-tieno (2,3-d) pirimidas. | |
KR830006326A (ko) | 이스타마이신(istamycin) B계 화합물의 3-0-데메틸 유도체의 제조방법 | |
JPS55329A (en) | Novel xk-62-4 derivative | |
ES8402315A1 (es) | Procedimiento para preparar derivados de aminoglicosidos. | |
GB874028A (en) | Derivatives of antibiotics having a basic reaction, and a process for their preparation | |
GB1161908A (en) | Antibiotically Active Derivatives of Rifamycin S and Rifamycin SV and Process for their Manufacture | |
JPS5782399A (en) | 2-deoxystreptamine aminoglycoside derivative and manufacture |